MM402 (R(-)-MDMA) — Initial data
2026
DT402 Initial Data in ASD | 2026Source filing
DFTX biotech catalysts & pipeline
DEFINIUM THERAPEUTICS INC · Data as of 2026-10-25
Upcoming catalysts
MM120 ODT — Topline data
H2 2026
Topline data from the 12-week double-blind period (Part A) is anticipated in the second half of 2026.Source filing
DT120 ODT — FDA meeting
4Q 2026
Pre-NDA meeting scheduled in 4Q 2026; NDA filing anticipated in 1H 2027Source filing
DT120 ODT — Topline data
2027
Topline data expected in 2027.Source filing
DT120 ODT — NDA/BLA submission
1H 2027
Pre-NDA meeting scheduled in 4Q 2026; NDA filing anticipated in 1H 2027Source filing